During the past decade, Mercy Cancer Institute at Mercy Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 6 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Cancer Institute at Mercy Hospital" #1 sponsor was "Radiation Therapy Oncology Group" with 5 trials, followed by "University of Pittsburgh" with 2 trials sponsored, "Ahmad Tarhini" with 1 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored and "NSABP Foundation Inc" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Cancer Institute at Mercy Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Cancer Institute at Mercy Hospital" are "Breast Cancer" (2 trials), "Adenoid Cystic Carcinoma" (1 trials), "Anal Cancer" (1 trials), "Cervical Cancer" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Mercy Cancer Institute at Mercy Hospital" in a lesser frequency.

Most popular intervention types in "Mercy Cancer Institute at Mercy Hospital" are "Drug" (9 trials), "Radiation" (6 trials), "Other" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (4 trials), "cisplatin" (3 trials), "tamoxifen citrate" (2 trials), "Amifostine trihydrate" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Cancer Institute at Mercy Hospital" are 7 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Mercy Cancer Institute at Mercy Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Mercy Cancer Institute at Mercy Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Cancer Institute at Mercy Hospital, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".